Compare Pfizer with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs JUBILANT PHARMOVA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER JUBILANT PHARMOVA PFIZER/
JUBILANT PHARMOVA
 
P/E (TTM) x 46.4 13.1 353.3% View Chart
P/BV x 7.7 2.5 314.1% View Chart
Dividend Yield % 0.4 0.6 73.0%  

Financials

 PFIZER   JUBILANT PHARMOVA
EQUITY SHARE DATA
    PFIZER
Mar-19
JUBILANT PHARMOVA
Mar-19
PFIZER/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs3,840898 427.6%   
Low Rs2,080618 336.8%   
Sales per share (Unadj.) Rs455.0572.0 79.5%  
Earnings per share (Unadj.) Rs93.836.2 258.9%  
Cash flow per share (Unadj.) Rs109.459.5 183.8%  
Dividends per share (Unadj.) Rs22.504.50 500.0%  
Dividend yield (eoy) %0.80.6 128.0%  
Book value per share (Unadj.) Rs658.2301.9 218.0%  
Shares outstanding (eoy) m45.75159.28 28.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.51.3 491.1%   
Avg P/E ratio x31.620.9 150.9%  
P/CF ratio (eoy) x27.112.7 212.5%  
Price / Book Value ratio x4.52.5 179.2%  
Dividend payout %24.012.4 193.1%   
Avg Mkt Cap Rs m135,420120,694 112.2%   
No. of employees `0002.62.4 110.1%   
Total wages/salary Rs m3,23819,260 16.8%   
Avg. sales/employee Rs Th7,911.438,120.6 20.8%   
Avg. wages/employee Rs Th1,230.98,058.4 15.3%   
Avg. net profit/employee Rs Th1,630.72,414.3 67.5%   
INCOME DATA
Net Sales Rs m20,81591,108 22.8%  
Other income Rs m1,674357 468.4%   
Total revenues Rs m22,48991,466 24.6%   
Gross profit Rs m5,71217,390 32.8%  
Depreciation Rs m7143,709 19.2%   
Interest Rs m732,198 3.3%   
Profit before tax Rs m6,59911,840 55.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m2,3093,268 70.6%   
Profit after tax Rs m4,2915,770 74.4%  
Gross profit margin %27.419.1 143.8%  
Effective tax rate %35.027.6 126.8%   
Net profit margin %20.66.3 325.5%  
BALANCE SHEET DATA
Current assets Rs m27,16745,848 59.3%   
Current liabilities Rs m8,91720,897 42.7%   
Net working cap to sales %87.727.4 320.2%  
Current ratio x3.02.2 138.9%  
Inventory Days Days6857 119.4%  
Debtors Days Days3051 59.1%  
Net fixed assets Rs m8,86265,498 13.5%   
Share capital Rs m458159 287.2%   
"Free" reserves Rs m29,65647,930 61.9%   
Net worth Rs m30,11348,089 62.6%   
Long term debt Rs m2542,429 0.1%   
Total assets Rs m39,400114,685 34.4%  
Interest coverage x91.56.4 1,433.0%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.50.8 66.5%   
Return on assets %11.16.9 159.4%  
Return on equity %14.212.0 118.7%  
Return on capital %22.112.4 178.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42812,422 3.4%   
Fx outflow Rs m78617,227 4.6%   
Net fx Rs m-358-4,805 7.5%   
CASH FLOW
From Operations Rs m97811,215 8.7%  
From Investments Rs m351-10,118 -3.5%  
From Financial Activity Rs m-1,0996,574 -16.7%  
Net Cashflow Rs m2317,612 3.0%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 63.9 3.5 1,825.7%  
Indian inst/Mut Fund % 7.5 8.7 86.2%  
FIIs % 4.9 21.2 23.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 21.1 112.3%  
Shareholders   85,207 23,815 357.8%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   WOCKHARDT  J.B.CHEMICALS  SHASUN PHARMA  BIOCON   FULFORD INDIA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun(Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel(Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 13, 2021 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS